Improving Glucocorticoid Sensitivity of Brain-Homing CD4 + T Helper Cells by Steroid Hormone Crosstalk

In early multiple sclerosis (MS), an IFN-γ GM-CSF IL-17 CD4 T-cell subset termed T helper 17.1 (Th17.1) reveals enhanced capacity to infiltrate the central nervous system. Th17.1 cells express high levels of multidrug resistance protein 1 (MDR1), which contributes to their poor glucocorticoid responsiveness. In this study, we explored whether glucocorticoid sensitivity of Th17.1 cells can generically be improved through synergy between steroid hormones, including calcitriol (1,25(OH) D ), estradiol (E2) and progesterone (P4). We showed that human blood Th17.1 cells were less sensitive to 1,25(OH) D than Th17 cells, as reflected by lower vitamin D receptor ( ) levels and reduced modulation of MDR1, IFN-γ and GM-CSF expression after 1,25(OH) D exposure. Upon T-cell activation, levels were increased, but still lower in Th17.1 versus Th17 cells, which was accompanied by a 1,25(OH) D -mediated decline in MDR1 surface expression as well as secretion of IFN-γ and GM-CSF. In activated Th17.1 cells, 1,25(OH) D amplified the suppressive effects of methylprednisolone (MP) on proliferation, MDR1 surface levels, secretion of IFN-γ and granzyme B, as well as expression of brain-homing markers CCR6 and VLA-4. The addition of P4 to 1,25(OH) D further enhanced MP-mediated reduction in proliferation, CD25, CCR6 and CXCR3. Overall, this study indicates that glucocorticoid sensitivity of Th17.1 cells can be enhanced by treatment with 1,25(OH) D and further improved with P4. Our observations implicate steroid hormone crosstalk as a therapeutic avenue in Th17.1-associated inflammatory diseases including MS.